Table 1 |
||||
|
Summary of studies assessing the relationship between inflammation on baseline STIR MRI of the spine and development of new syndesmophytes after 2 years of follow up |
||||
|
Number of patients with new syndesmophytes at 2 years |
||||
|
|
||||
|
Study |
Yes |
No |
OR (95% CI) |
P-value |
|
|
||||
|
Baraliakos et al. [19] |
||||
|
Baseline VE+ (n = 163; 17.2%) |
10 (6.5%) |
153 (93.5%) |
3.1 (1.4-7.1) |
0.007 |
|
Baseline VE- (n = 785; 82.8%) |
16 (2.1%) |
769 (97.9%) |
||
|
Maksymowych et al. [20] |
||||
|
Anti-TNFα trial patients |
||||
|
Baseline CIL+ (n = 30) |
6 (20%) |
24 (80%) |
4.6 (1.7-12.6) |
0.007 |
|
Baseline CIL- (n = 370) |
19 (5.1%) |
351 (94.9%) |
||
|
Observational cohort patients |
||||
|
Baseline CIL+ (n = 28) |
6 (15.8%) |
32(84.2%) |
6.3 (2.4-16.7) |
0.001 |
|
Baseline CIL- (n = 617) |
23 (2.9%) |
778 (97.1%) |
||
|
Van der Heijde et al. [21] |
||||
|
Baseline DVU+ (n = 297) |
36 (12.1%) |
261 (87.9%) |
1.9 (1.3-2.8) |
0.002 |
|
Baseline DVU- (n = 1,707) |
115 (6.7%) |
1,592 (93.3%) |
||
|
|
||||
|
CIL, vertebral corner inflammatory lesion [20]; DVU, discovertebral unit [21]; OR, odds ratio; STIR, short tau inversion recovery; VE, vertebral edge [19]. |
||||
|
Maksymowych Arthritis Research & Therapy 2012 14:207 doi:10.1186/ar3786 |
||||